Mark J. Mulligan

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh, Robert W. Frenck, Ann R. Falsey et al. · New England Journal of Medicine · 2020 · 2.7K citations · Full text

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Mark J. Mulligan, Kirsten E. Lyke, Nicholas Kitchin et al. · Nature · 2020 · 1.6K citations · Full text

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

Troy D. Querec, Rama Akondy, Eva K. Lee et al. · Nature Immunology · 2008 · 1.1K citations · Full text

Vaccination, Vaccine Development, Medicine +9

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

Jens Wrammert, Dimitrios Koutsonanos, Guimei Li et al. · The Journal of Experimental Medicine · 2011 · 797 citations · Full text

Vaccination, Pandemic H1n1, Vaccine Development +11

Molecular signatures of antibody responses derived from a systems biology study of five human vaccines

Shuzhao Li, Nadine Rouphael, Sai Duraisingham et al. · Nature Immunology · 2013 · 777 citations · Full text

Vaccination, Autoimmune Disease, Vaccine Target +13